More women with EARLY breast cancer will be treated with an aromatase inhibitor

More women with EARLY breast cancer will be treated with an aromatase inhibitor...Arimidex, Femara, Aromasin.

Until now, tamoxifen was considered the "gold standard" to prevent recurrence in women with early estrogen receptor-positive breast cancer.

Experts now recommend that most postmenopausal women should get an aromatase inhibitor...either as initial therapy or after receiving tamoxifen.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote